TXNIP and early-onset autosomal dominant Alzheimer disease: TXNIP has been considered an endogenous negative regulator in the TRX system with a pivotal role in central system diseases, such as stroke, subarachnoid hemorrhage, and Alzheimer's disease [23, 25].